Fund Evaluator:
Invesco Dorsey Wright Healthcare MomtETF (PTH)Equity
Global Asset Class
Sector Equity
Fund Group
Health
Category
$78.220
NAV (as of Oct 07)
$0.00
Minimum Initial
0.60% D
Expense Ratio
$235 Mil
Assets
Open
Status
na
12b-1 Fee
2.63%
TTM Yield
0.00%
Max Load
239%
Portfolio Turnover
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Data as of 7/31/2026
-2.6% D
1-Mo Return
14.8% B
3-Mo Return
16.8% B
YTD Return
58.1% A
1-Yr Return
15.5% B
3-Yr Return
1.6% D
5-Yr Return
1.28 F
Category Risk Index
2.10
Total Risk Index
Fund Details
Fund Family
Invesco
Inception Date
10/12/2006
Share Class Type
Equity Investment Style
Small-Cap
Growth
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
Yes
Benchmark Index
NASDAQ Composite TR USD: 100%
Additional Fund Details
Invesco Dorsey Wright Healthcare MomtETF Overview
PTH Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| PTH Return (NAV) | -2.6% | 14.8% | 58.1% | 15.5% | 1.6% | 13.9% |
| PTH Grade | D | B | A | B | D | A |
| +/- Category | -2.3% | 4.1% | 24.3% | 4.9% | -3.3% | 4.6% |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| PTH Tax Cost Ratio | na | na | 1.2% | 0.4% | 0.2% | 0.1% |
PTH Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| PTH Return (NAV) | 16.8% | 28.1% | 2.0% | -4.4% | -20.7% | -3.0% | 67.1% | 33.8% | -0.9% | 50.1% | -12.9% |
| PTH Grade | B | B | C | F | D | D | A | A | C | A | C |
| +/- Category | 9.7% | 7.5% | -0.5% | -9.9% | -11.3% | -11.8% | 42.7% | 5.4% | -1.2% | 26.7% | -2.0% |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 25.7% |
| Total Risk Index: | 2.10 - High |
| Category Risk Index: | 1.28 - High |
| Category Risk Grade: | F (89% Rank) |
| Beta: | 1.01 |
| R-Squared: | 25% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Small-Cap Growth |
| Bond Investment Style: | na |
| Yield: | 2.6% |
| Dividend Distribution: | Quarterly |
| Cap Gains Distribution: | Annually |
| Total Assets: | $235 Mil |
| Fund Total Assets: | $ 235 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 239% |
Management Team
| Number of Managers: 3 | |||
| Longest Tenure: 19.2 years | |||
| Average Tenure: 14.3 years | |||
| Managers (Year): Hubbard Peter (2007), Jeanette Michael (2008), Doshi Pratik (2020) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 55 |
| % in Top 10 Holdings: | 36.2% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 6.4% |
Portfolio Allocation |
|
| Domestic Stock: | 93.5% |
| Foreign Stock: | 6.4% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.1% |
Purchase Information
| Fund Family: | Invesco |
| Phone Number: | 800-983-0903 |
| Website: | www.invescopowershares.com |
| Status: | Open |
| Inception Date: | October 12, 2006 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.60% ( Rating : Above Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Invesco Dorsey Wright Healthcare MomtETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.